TABLE 1.
Patient demographic characteristics and disease characteristics
| Characteristic | Number of patients (n = 451) |
|---|---|
| Age, median (IQR) | 62.1 (53.8-70.1) |
| Male, no. (%) | 285 (63.2) |
| Race/ethnicity, no. (%) | |
| White | 279 (61.9) |
| Asian | 31 (6.9) |
| Black | 29 (6.4) |
| Hispanic | 51 (11.3) |
| Other | 61 (13.5) |
| Tumor location, no. (%) | |
| Gastroesophageal junction or cardia | 211 (46.8) |
| Antrum/body/fundus | 215 (47.7) |
| Entire stomach | 25 (5.5) |
| Grade, no. (%) | |
| Poorly differentiated | 307 (68.1) |
| Moderately differentiated | 105 (23.3) |
| Well differentiated | 2 (0.4) |
| Unknown | 37 (8.2) |
| Linitis, yes | 41 (9.1%) |
| Signet-ring cell morphology, yes | 213 (47.2%) |
| cT stage | |
| T1 | 48 (10.6%) |
| T2 | 8 (1.8%) |
| T3 | 357 (79.2%) |
| T4 | 38 (8.4%) |
| cN stage | |
| N0 | 149 (33.0%) |
| N1+ | 301 (66.7%) |
| Pre-operative therapy type | |
| Chemotherapy and radiation | 391 (86.7) |
| Chemotherapy only | 60 (13.3) |
| Delayed surgery > 8 months | |
| Yes | 98 (21.7%) |
| No | 353 (78.3%) |
IQR, interquartile range.